MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Ocugen, Inc. (OCGN) on Wednesday reported a loss of $13.9 million in its fourth quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 5 cents.
The biotech knee implant developer posted revenue of $764,000 in the period.
For the year, the company reported a loss of $54 million, or 20 cents per share. Revenue was reported as $4.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCGN at https://www.zacks.com/ap/OCGN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.